Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network: An initial study in GSC11 glioblastoma stem cells

Carol L. Nilsson, Roslyn Dillon, Arugadoss Devakumar, Stone D H Shi, Michael Greig, John C. Rogers, Bryan Krastins, Michael Rosenblatt, Gregory Kilmer, Michael Major, Barbara J. Kaboord, David Sarracino, Taha Rezai, Amol Prakash, Mary Lopez, Yongjie Ji, Waldemar Priebe, Frederick F. Lang, Howard Colman, Charles A. Conrad

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Initiation and maintenance of several cancers including glioblastoma (GBM) may be driven by a small subset of cells called cancer stem cells (CSCs). CSCs may provide a repository of cells in tumor cell populations that are refractory to chemotherapeutic agents developed for the treatment of tumors. STAT3 is a key transcription factor associated with regulation of multiple stem cell types. Recently, a novel autocrine loop (IL-6/STAT3/HIF1α) has been observed in multiple tumor types (pancreatic, prostate, lung, and colon). The objective of this study was to probe perturbations of this loop in a glioblastoma cancer stem cell line (GSC11) derived from a human tumor by use of a JAK2/STAT3 phosphorylation inhibitor (WP1193), IL-6 stimulation, and hypoxia. A quantitative phosphoproteomic approach that employed phosphoprotein enrichment, chemical tagging with isobaric tags, phosphopeptide enrichment, and tandem mass spectrometry in a high-resolution instrument was applied. A total of 3414 proteins were identified in this study. A rapid Western blotting technique (<1 h) was used to confirm alterations in key protein expression and phosphorylation levels observed in the mass spectrometric experiments. About 10% of the phosphoproteins were linked to the IL-6 pathway, and the majority of remaining proteins could be assigned to other interlinked networks. By multiple comparisons between the sample conditions, we observed expected changes and gained novel insights into the contribution of each factor to the IL6/STAT3/HIF1α autocrine loop and the CSC response to perturbations by hypoxia, inhibition of STAT3 phosphorylation, and IL-6 stimulation.

Original languageEnglish (US)
Pages (from-to)430-443
Number of pages14
JournalJournal of Proteome Research
Volume9
Issue number1
DOIs
StatePublished - Jan 4 2010
Externally publishedYes

Fingerprint

Glioblastoma
Stem cells
Neoplastic Stem Cells
Interleukin-6
Stem Cells
Phosphorylation
Tumors
Chemical analysis
Phosphoproteins
Neoplasms
Phosphopeptides
Proteins
Tandem Mass Spectrometry
Refractory materials
Mass spectrometry
Prostate
Colon
Transcription Factors
Western Blotting
Cells

Keywords

  • Cancer stem cells
  • Glioblastoma multiforme
  • HIF1α
  • IL-6
  • LC-MS/MS
  • LTQ-Orbitrap
  • Phosphopeptide enrichment
  • Quantitative phosphoproteomics
  • STAT3 phosphorylation inhibition
  • Western blot

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Nilsson, C. L., Dillon, R., Devakumar, A., Shi, S. D. H., Greig, M., Rogers, J. C., ... Conrad, C. A. (2010). Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network: An initial study in GSC11 glioblastoma stem cells. Journal of Proteome Research, 9(1), 430-443. https://doi.org/10.1021/pr9007927

Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network : An initial study in GSC11 glioblastoma stem cells. / Nilsson, Carol L.; Dillon, Roslyn; Devakumar, Arugadoss; Shi, Stone D H; Greig, Michael; Rogers, John C.; Krastins, Bryan; Rosenblatt, Michael; Kilmer, Gregory; Major, Michael; Kaboord, Barbara J.; Sarracino, David; Rezai, Taha; Prakash, Amol; Lopez, Mary; Ji, Yongjie; Priebe, Waldemar; Lang, Frederick F.; Colman, Howard; Conrad, Charles A.

In: Journal of Proteome Research, Vol. 9, No. 1, 04.01.2010, p. 430-443.

Research output: Contribution to journalArticle

Nilsson, CL, Dillon, R, Devakumar, A, Shi, SDH, Greig, M, Rogers, JC, Krastins, B, Rosenblatt, M, Kilmer, G, Major, M, Kaboord, BJ, Sarracino, D, Rezai, T, Prakash, A, Lopez, M, Ji, Y, Priebe, W, Lang, FF, Colman, H & Conrad, CA 2010, 'Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network: An initial study in GSC11 glioblastoma stem cells', Journal of Proteome Research, vol. 9, no. 1, pp. 430-443. https://doi.org/10.1021/pr9007927
Nilsson, Carol L. ; Dillon, Roslyn ; Devakumar, Arugadoss ; Shi, Stone D H ; Greig, Michael ; Rogers, John C. ; Krastins, Bryan ; Rosenblatt, Michael ; Kilmer, Gregory ; Major, Michael ; Kaboord, Barbara J. ; Sarracino, David ; Rezai, Taha ; Prakash, Amol ; Lopez, Mary ; Ji, Yongjie ; Priebe, Waldemar ; Lang, Frederick F. ; Colman, Howard ; Conrad, Charles A. / Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network : An initial study in GSC11 glioblastoma stem cells. In: Journal of Proteome Research. 2010 ; Vol. 9, No. 1. pp. 430-443.
@article{abc3ddd0534445949692b3529e2c8923,
title = "Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network: An initial study in GSC11 glioblastoma stem cells",
abstract = "Initiation and maintenance of several cancers including glioblastoma (GBM) may be driven by a small subset of cells called cancer stem cells (CSCs). CSCs may provide a repository of cells in tumor cell populations that are refractory to chemotherapeutic agents developed for the treatment of tumors. STAT3 is a key transcription factor associated with regulation of multiple stem cell types. Recently, a novel autocrine loop (IL-6/STAT3/HIF1α) has been observed in multiple tumor types (pancreatic, prostate, lung, and colon). The objective of this study was to probe perturbations of this loop in a glioblastoma cancer stem cell line (GSC11) derived from a human tumor by use of a JAK2/STAT3 phosphorylation inhibitor (WP1193), IL-6 stimulation, and hypoxia. A quantitative phosphoproteomic approach that employed phosphoprotein enrichment, chemical tagging with isobaric tags, phosphopeptide enrichment, and tandem mass spectrometry in a high-resolution instrument was applied. A total of 3414 proteins were identified in this study. A rapid Western blotting technique (<1 h) was used to confirm alterations in key protein expression and phosphorylation levels observed in the mass spectrometric experiments. About 10{\%} of the phosphoproteins were linked to the IL-6 pathway, and the majority of remaining proteins could be assigned to other interlinked networks. By multiple comparisons between the sample conditions, we observed expected changes and gained novel insights into the contribution of each factor to the IL6/STAT3/HIF1α autocrine loop and the CSC response to perturbations by hypoxia, inhibition of STAT3 phosphorylation, and IL-6 stimulation.",
keywords = "Cancer stem cells, Glioblastoma multiforme, HIF1α, IL-6, LC-MS/MS, LTQ-Orbitrap, Phosphopeptide enrichment, Quantitative phosphoproteomics, STAT3 phosphorylation inhibition, Western blot",
author = "Nilsson, {Carol L.} and Roslyn Dillon and Arugadoss Devakumar and Shi, {Stone D H} and Michael Greig and Rogers, {John C.} and Bryan Krastins and Michael Rosenblatt and Gregory Kilmer and Michael Major and Kaboord, {Barbara J.} and David Sarracino and Taha Rezai and Amol Prakash and Mary Lopez and Yongjie Ji and Waldemar Priebe and Lang, {Frederick F.} and Howard Colman and Conrad, {Charles A.}",
year = "2010",
month = "1",
day = "4",
doi = "10.1021/pr9007927",
language = "English (US)",
volume = "9",
pages = "430--443",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1α signaling network

T2 - An initial study in GSC11 glioblastoma stem cells

AU - Nilsson, Carol L.

AU - Dillon, Roslyn

AU - Devakumar, Arugadoss

AU - Shi, Stone D H

AU - Greig, Michael

AU - Rogers, John C.

AU - Krastins, Bryan

AU - Rosenblatt, Michael

AU - Kilmer, Gregory

AU - Major, Michael

AU - Kaboord, Barbara J.

AU - Sarracino, David

AU - Rezai, Taha

AU - Prakash, Amol

AU - Lopez, Mary

AU - Ji, Yongjie

AU - Priebe, Waldemar

AU - Lang, Frederick F.

AU - Colman, Howard

AU - Conrad, Charles A.

PY - 2010/1/4

Y1 - 2010/1/4

N2 - Initiation and maintenance of several cancers including glioblastoma (GBM) may be driven by a small subset of cells called cancer stem cells (CSCs). CSCs may provide a repository of cells in tumor cell populations that are refractory to chemotherapeutic agents developed for the treatment of tumors. STAT3 is a key transcription factor associated with regulation of multiple stem cell types. Recently, a novel autocrine loop (IL-6/STAT3/HIF1α) has been observed in multiple tumor types (pancreatic, prostate, lung, and colon). The objective of this study was to probe perturbations of this loop in a glioblastoma cancer stem cell line (GSC11) derived from a human tumor by use of a JAK2/STAT3 phosphorylation inhibitor (WP1193), IL-6 stimulation, and hypoxia. A quantitative phosphoproteomic approach that employed phosphoprotein enrichment, chemical tagging with isobaric tags, phosphopeptide enrichment, and tandem mass spectrometry in a high-resolution instrument was applied. A total of 3414 proteins were identified in this study. A rapid Western blotting technique (<1 h) was used to confirm alterations in key protein expression and phosphorylation levels observed in the mass spectrometric experiments. About 10% of the phosphoproteins were linked to the IL-6 pathway, and the majority of remaining proteins could be assigned to other interlinked networks. By multiple comparisons between the sample conditions, we observed expected changes and gained novel insights into the contribution of each factor to the IL6/STAT3/HIF1α autocrine loop and the CSC response to perturbations by hypoxia, inhibition of STAT3 phosphorylation, and IL-6 stimulation.

AB - Initiation and maintenance of several cancers including glioblastoma (GBM) may be driven by a small subset of cells called cancer stem cells (CSCs). CSCs may provide a repository of cells in tumor cell populations that are refractory to chemotherapeutic agents developed for the treatment of tumors. STAT3 is a key transcription factor associated with regulation of multiple stem cell types. Recently, a novel autocrine loop (IL-6/STAT3/HIF1α) has been observed in multiple tumor types (pancreatic, prostate, lung, and colon). The objective of this study was to probe perturbations of this loop in a glioblastoma cancer stem cell line (GSC11) derived from a human tumor by use of a JAK2/STAT3 phosphorylation inhibitor (WP1193), IL-6 stimulation, and hypoxia. A quantitative phosphoproteomic approach that employed phosphoprotein enrichment, chemical tagging with isobaric tags, phosphopeptide enrichment, and tandem mass spectrometry in a high-resolution instrument was applied. A total of 3414 proteins were identified in this study. A rapid Western blotting technique (<1 h) was used to confirm alterations in key protein expression and phosphorylation levels observed in the mass spectrometric experiments. About 10% of the phosphoproteins were linked to the IL-6 pathway, and the majority of remaining proteins could be assigned to other interlinked networks. By multiple comparisons between the sample conditions, we observed expected changes and gained novel insights into the contribution of each factor to the IL6/STAT3/HIF1α autocrine loop and the CSC response to perturbations by hypoxia, inhibition of STAT3 phosphorylation, and IL-6 stimulation.

KW - Cancer stem cells

KW - Glioblastoma multiforme

KW - HIF1α

KW - IL-6

KW - LC-MS/MS

KW - LTQ-Orbitrap

KW - Phosphopeptide enrichment

KW - Quantitative phosphoproteomics

KW - STAT3 phosphorylation inhibition

KW - Western blot

UR - http://www.scopus.com/inward/record.url?scp=73649140983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649140983&partnerID=8YFLogxK

U2 - 10.1021/pr9007927

DO - 10.1021/pr9007927

M3 - Article

C2 - 19899826

AN - SCOPUS:73649140983

VL - 9

SP - 430

EP - 443

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 1

ER -